Redox FY26 presentation: record revenue, profit surge as shares slip

Redox Limited, a chemical distributor listed on the ASX, disclosed its FY 2026 results on August 20, 2026. The company announced record revenue of $1.330 billion, a 6.9% increase year-over-year, along with a notable 19.2% surge in net profit, reaching $92 million. Despite these impressive figures, Redox shares fell 3.16% to $3.68 following the announcement.

The presentation attributed the strong performance to a combination of organic growth and strategic acquisitions, including the Molekulis acquisition in April 2025. Gross profit margins expanded by 0.8 percentage points to 22.4%, reflecting favorable shifts in product mix and pricing strategies, particularly in North America. EBITDAFX grew to $134 million, marking a 10.1% margin on sales.

The company's 30-year revenue trajectory showcases consistent long-term growth, with a 10.1% compound annual growth rate. Redox's financial health is underscored by a robust return on invested capital of 14.6%, and the company maintained its dividend payout ratio within the 60-80% target range, declaring a final dividend of 6.5 cents per share, totaling 13 cents for the year.

Notably, North America emerged as the primary growth engine, with sales surging 33.8% to exceed $100 million for the first time. This expansion was driven by increased customer conversions, market share gains across various sectors, and the addition of new products, particularly in the U.S. Southeast and Canadian markets.